(Total Views: 511)
Posted On: 06/02/2020 10:42:54 PM
Post# of 148984
Re: Rex Eupseiphos #36370
Agreed. These are valid concerns, and I have been having some trouble clearing them from my mind in recent days.
Is it possible that the confidence exhibited by our CytoDyn doctors (BP, JL, NP) is based entirely on "Other Outcome Measures" and less on "Primary Outcome Measures". As I understand it, they cannot really have any insight into the symptomatic improvement of these patients.
And is it possible this confidence is misplaced in terms of the metrics that the FDA are going to base their approval decision on?
This is a question I'd really like to pose to Dr. NP and Dr. JL.
Is it possible that the confidence exhibited by our CytoDyn doctors (BP, JL, NP) is based entirely on "Other Outcome Measures" and less on "Primary Outcome Measures". As I understand it, they cannot really have any insight into the symptomatic improvement of these patients.
And is it possible this confidence is misplaced in terms of the metrics that the FDA are going to base their approval decision on?
This is a question I'd really like to pose to Dr. NP and Dr. JL.
(0)
(0)Scroll down for more posts ▼
